INTERVIEW: Mylan set to rev up Indian ops but wants policy stability

If plans outlined by the multinational generic company's president are anything to go by, Mylan appears set for a major expansion in India, boosted by its recent acquisition of local firm Agila Specialties, although it is maintaining a generally cautious stance over policy-related uncertainties in the country.

More from Alimentary/Metabolic

More from Therapy Areas